Liver tests abnormalities with licensed antiviral drugs for COVID-19: a narrative review
Author:
Affiliation:
1. Department of Biomedical and Clinical Sciences, Università Degli Studi Di Milano, Milan, Italy
2. III Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2160446
Reference59 articles.
1. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
2. Clinical Features of COVID-19-Related Liver Functional Abnormality
3. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
4. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
5. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study;Scientific Reports;2024-02-09
2. Favipiravir Analogues as Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase, Combined Quantum Chemical Modeling, Quantitative Structure–Property Relationship, and Molecular Docking Study;Molecules;2024-01-16
3. COVID-19 and suspected drug-induced liver injury;Features, Transmission, Detection, and Case Studies in COVID-19;2024
4. In vitro testing of host-targeting small molecule antiviral matriptase/TMPRSS2 inhibitors in 2D and 3D cell-based assays;Biomedicine & Pharmacotherapy;2023-12
5. Development and Validation of In-vitro Release Study of Molnupiravir Capsules by RP-HPLC;Current Pharmaceutical Analysis;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3